SP1 and neuroblastoma: This was given emphasis when Siaw and colleagues proposed that ALK activation in neuroblastoma can inhibit DLG2 transcription via ERK1/2 and specificity protein 1 (SP1) signalling, thus impairing DLG2-induced differentiation.